泰豪科技(600590.SH):子公司擬與持股平台共設軍工產業孵化平台
格隆匯12月10日丨泰豪科技(600590.SH)公佈,公司全資子公司江西泰豪軍工集團有限公司(“泰豪軍工”)擬與公司軍工裝備產業核心員工持股平台共青城科發共創合夥企業(有限合夥)(暫定名,“科發共創”或“持股平台”)共同出資5000.00萬元新設上海泰豪科創發展有限公司(暫定名,以下簡稱“科創發展”或“孵化平台”),註冊資本為5000.00萬元。
其中,泰豪軍工出資3500.00萬元,持有合資公司70%股權,合夥企業出資1500.00萬元,持有合資公司30%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.